We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Brown Fat Hormone Signaling Prevents Obesity by Modulating Liver Lipid Metabolism

By LabMedica International staff writers
Posted on 25 Nov 2014
Print article
A hormone produced by brown adipose tissue has been determined to modulate the activity of liver cells that metabolize sugar into fats and is apparently linked to the development of metabolic disorders such as type II diabetes, nonalcoholic fatty liver disease, and obesity.

Investigators at the University of Michigan (Ann Arbor, USA) worked with genetically engineered mice in which the production of the hormone neuregulin 4 (Nrg4) was either blocked or enhanced. The neuregulins, including NRG4, activate type-1 growth factor receptors to initiating cell-to-cell signaling through tyrosine phosphorylation.

In a paper published in the November 17, 2014, online edition of the journal Nature Medicine, the investigators reported that Nrg4 was highly expressed in adipose tissues, enriched in brown fat, and markedly increased during brown adipocyte differentiation. Adipose tissue Nrg4 expression was reduced in rodent and human obesity. Gain- and loss-of-function studies in genetically engineered mice demonstrated that Nrg4 protected against diet-induced insulin resistance and accumulation of fats in the liver by reducing lipogenic signaling.

Mice genetically engineered to lack the gene for NRG4 became obese and developed symptoms of type II diabetes and fatty liver disease. Animals in which NRG4 levels were genetically elevated were protected from these metabolic disorders when fed a high-calorie, high-fat diet.

Senior author Dr. Jiandie Lin, associate professor of cell and developmental biology at the University of Michigan, said, "In all models of obesity, NRG4 expression is reduced. We think obesity is a state of NRG4 deficiency. Realistically, there are still many challenges to figuring out how it acts in the body and might be used as a drug, but in general, we know that NRG4 is beneficial for body metabolism and are excited about its potential."

Related Links:

University of Michigan


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.